Delayed puberty

Functional Causes (most common):

  • Constitutional Delay of Puberty and Growth:
    • This is the most frequent cause of delayed puberty in healthy girls. It is a variant of normal development where puberty begins later but without any underlying health issues. Often, there is a family history; parents or siblings may have experienced delayed puberty.
  • Energy Imbalance:
    • Underweight: A very low body fat percentage, for example, caused by eating disorders like anorexia nervosa, can delay puberty development.
    • Excessive Exercise: Intense physical activity, especially among female athletes, can affect hypothalamic function and delay puberty.
  • Psychological Stress:
    • Emotional stress or chronic psychological strain can delay puberty by influencing the hypothalamic-pituitary-gonadal axis through stress hormones.

Delayed Puberty Organic Causes

Diagnosis 

Diagnosing delayed puberty involves thorough evaluation to distinguish between constitutional delay and organic causes.

  1. Medical History and Physical Examination:
    • Document family history of delayed puberty (e.g., parents or siblings).
    • Assess growth patterns and development of secondary sexual characteristics.
    • Identify signs of underweight, excessive exercise, or psychological stress.
  2. Bone Age Assessment:
    • An X-ray of the hand determines bone age.
    • Delayed bone age is typical for constitutional delay, whereas it may be normal or less delayed in organic causes.
  3. Laboratory Tests:
    • Hormone Levels:
      • LH and FSH: Low levels suggest hypogonadotropic hypogonadism, while high levels indicate hypergonadotropic hypogonadism (e.g., Turner syndrome, POI).
      • Estradiol: Low levels confirm insufficient ovarian stimulation or dysfunction.
    • Thyroid Function (TSH, free T4): To exclude hypothyroidism.
    • Prolactin: Elevated levels may indicate a prolactinoma (pituitary tumor).
    • Blood Sugar and Metabolic Parameters: To rule out chronic illnesses.
  4. Genetic Testing:
    • If Turner syndrome or another genetic disorder is suspected, karyotype analysis and genetic tests are performed.
    •  

Kallmann Syndrome

Kallmann Syndrome is a rare genetic disorder characterized by the combination of hypogonadotropic hypogonadism (a condition where the body produces insufficient sex hormones due to low levels of gonadotropins) and anosmia or hyposmia (absent or reduced sense of smell). It primarily affects puberty and reproductive development.

Causes of Kallmann Syndrome

Kallmann Syndrome is caused by a defect in the migration of GnRH (gonadotropin-releasing hormone) neurons during embryonic development. These neurons, which originate in the olfactory bulb, fail to reach the hypothalamus, where they would normally regulate the production of gonadotropins (LH and FSH) through the hypothalamic-pituitary-gonadal (HPG) axis. This results in insufficient production of sex hormones.

The condition is genetic and can be inherited in different patterns:

  1. X-linked recessive inheritance (most common; mutations in the KAL1 gene).
  2. Autosomal dominant inheritance (mutations in genes like FGFR1).
  3. Autosomal recessive inheritance.

Symptoms of Kallmann Syndrome

  1. Delayed or Absent Puberty:
    • Lack of development of secondary sexual characteristics (e.g., breast development in females, facial hair or voice changes in males).
    • Primary amenorrhea (no menstruation) in females.
    • Infertility due to lack of gonadotropin stimulation.
  2. Anosmia or Hyposmia:
    • Complete or reduced sense of smell, which is a hallmark feature of Kallmann Syndrome.
  3. Other Possible Symptoms:
    • Cleft lip or palate.
    • Abnormalities in eye movement (e.g., color blindness, ptosis).
    • Hearing loss.
    • Renal agenesis (one kidney fails to develop).
    • Short stature (in some cases).
    • Skeletal abnormalities, such as a missing digit.

 

Diagnosis of Kallmann Syndrome

  1. Clinical Examination:
    • Delayed or absent puberty and anosmia/hyposmia are key diagnostic indicators.
  2. Hormone Testing:
    • Low levels of LH and FSH, as well as low levels of sex hormones (testosterone in males, estrogen in females).
  3. Olfactory Testing:
    • Testing for sense of smell through olfactory function tests.
  4. Imaging:
    • MRI of the brain to detect abnormalities in the olfactory bulbs and hypothalamus.
  5. Genetic Testing:
    • Identification of mutations in genes like KAL1, FGFR1, PROK2, or PROKR2.

 

Treatment of Kallmann Syndrome

Treatment focuses on hormone replacement therapy to induce puberty and restore reproductive function:

  1. Hormone Replacement Therapy (HRT):
    • Males: Administration of testosterone to induce puberty and develop secondary sexual characteristics.
    • Females: Administration of estrogen and progesterone to promote breast development and menstruation.
  2. Gonadotropin Therapy:
    • For patients desiring fertility, treatment with hCG (human chorionic gonadotropin) and FSH can stimulate sperm production in males and ovulation in females.
  3. Psychological Support:
    • Counseling may be necessary to address emotional and social challenges.
  4. Surgical Correction:
    • For associated abnormalities like cleft lip or palate.

Prognosis

With appropriate hormone therapy, individuals with Kallmann Syndrome can achieve normal pubertal development, improve fertility, and lead healthy lives. Early diagnosis and intervention are key to preventing long-term complications such as osteoporosis (due to prolonged sex hormone deficiency).

    •  

Prader-Willi Syndrome (PWS)

Prader-Willi Syndrome (PWS) is a rare genetic disorder that affects multiple systems of the body and is characterized by hypotonia (low muscle tone), poor feeding in infancy, followed by insatiable hunger (hyperphagia) and obesity in childhood if food intake is not controlled. It also involves developmental delays, intellectual disabilities, and hormonal abnormalities.

Causes of Prader-Willi Syndrome

PWS is caused by the loss of function of specific genes located on the paternal chromosome 15 (15q11-q13 region). This genetic abnormality can occur due to:

  1. Paternal Deletion (70% of cases):
    • A portion of chromosome 15 inherited from the father is deleted.
  2. Maternal Uniparental Disomy (25% of cases):
    • The child inherits two copies of chromosome 15 from the mother and none from the father.
  3. Imprinting Defects (1-5% of cases):
    • Errors in genomic imprinting cause the paternal genes to be inactive.

 

Symptoms of Prader-Willi Syndrome

Infancy:

  1. Hypotonia (low muscle tone):
    • Infants appear “floppy” and have weak sucking reflexes, leading to poor feeding and failure to thrive.
  2. Delayed Motor Development:
    • Slower development of milestones like sitting, crawling, and walking.

Childhood and Beyond:

  1. Hyperphagia (insatiable appetite):
    • Beginning around age 2-4, children develop an uncontrollable appetite. This can lead to severe obesity if food intake is not strictly managed.
  2. Obesity and Related Health Issues:
    • Diabetes mellitus type 2
    • Sleep apnea
    • Cardiovascular problems
  3. Growth Hormone Deficiency:
    • Leads to short stature and poor muscle development.
  4. Hypogonadism:
    • Underdeveloped sexual organs, delayed or incomplete puberty, and infertility.
  5. Intellectual Disabilities:
    • Mild to moderate learning difficulties and cognitive delays.
  6. Behavioral Problems:
    • Temper tantrums, stubbornness, obsessive-compulsive traits, and sometimes self-harm.
  7. Distinctive Physical Features:
    • Narrow forehead, almond-shaped eyes, thin upper lip, and small hands and feet.
  8. Sleep Disorders:
    • Sleep apnea, excessive daytime sleepiness.

 

Diagnosis of Prader-Willi Syndrome

Diagnosis involves a combination of clinical features and genetic testing:

  1. Clinical Features: Hypotonia, feeding issues, obesity, growth failure, and behavioral symptoms.
  2. Genetic Testing:
    • Methylation analysis confirms PWS by detecting the absence of paternal genes on chromosome 15.
    • FISH (Fluorescence in situ hybridization): Detects deletions on the paternal chromosome 15.
    • Microarray or DNA sequencing can confirm uniparental disomy or imprinting defects.

 

Treatment of Prader-Willi Syndrome

There is no cure for PWS, but early intervention and management can significantly improve quality of life:

  1. Nutritional Management:
    • Strictly controlled diets and monitoring food intake to prevent obesity.
    • Locking food storage areas may be necessary in severe cases.
  2. Growth Hormone Therapy:
    • Improves growth, muscle tone, strength, and reduces fat accumulation.
  3. Hormonal Treatments:
    • Testosterone or estrogen replacement therapy for pubertal development in boys and girls, respectively.
  4. Physical Therapy and Exercise:
    • To improve muscle strength and mobility.
  5. Behavioral Therapy:
    • Manage behavioral issues like tantrums, obsessive behaviors, and compulsions.
  6. Educational Support:
    • Specialized education to address intellectual disabilities and learning delays.
  7. Sleep Management:
    • Treatments for sleep apnea, such as CPAP (Continuous Positive Airway Pressure).

Prognosis

With early diagnosis, proper medical care, and structured support, individuals with Prader-Willi Syndrome can lead fulfilling lives. However, lifelong management of diet, hormone deficiencies, and behavioral issues is required to prevent complications like obesity-related diseases.

Ulrich-Turner Syndrome

Ulrich-Turner Syndrome (Turner Syndrome)

Summary

Ulrich-Turner Syndrome (UTS), often called Turner Syndrome, is a genetic disorder that affects only girls and women. It is caused by the absence or structural alteration of one of the two X chromosomes. Affected women are typically short, do not undergo puberty, and are infertile. Characteristic features include a broad chest with widely spaced nipples and webbed neck folds. Associated conditions include thyroid disease, heart problems, and kidney anomalies. Treatment includes early growth hormone therapy and hormone replacement therapy (HRT).

Causes of Turner Syndrome

Turner Syndrome is caused by a chromosomal abnormality that results in the complete or partial absence of an X chromosome. It occurs early during embryonic development. The chromosomal variations include:

  1. Monosomy X (45,X):
    • Complete absence of one X chromosome, seen in 50-60% of cases.
  2. Mosaicism (Mosaic Turner Syndrome):
    • Some cells have the normal number of chromosomes (46,XX), while others have only one X chromosome (45,X). This occurs in 30% of cases and may cause milder symptoms.
  3. Structural Alterations of the X Chromosome:
    • This includes deletions, ring chromosomes, or partially missing X chromosomes.

The exact cause of the chromosomal anomaly is unknown, but it is thought to result from a random error during cell division (meiosis or mitosis). Environmental factors are not known to play a role.

Typical Features and Symptoms

Symptoms vary, but the most common features include:

  1. Short Stature: Girls with Turner Syndrome are significantly shorter than average.
  2. Delayed Puberty and Infertility: Underdeveloped ovaries cause incomplete or absent puberty, no menstruation, and infertility.
  3. Thyroid Problems: Autoimmune hypothyroidism (underactive thyroid) is common.
  4. Heart Defects: For example, coarctation of the aorta (narrowing of the aorta).
  5. Kidney Problems: Structural abnormalities may be present.
  6. Physical Features:
    • Broad chest with widely spaced nipples
    • Webbed neck folds (pterygium colli)
  7. Other Symptoms:
    • Lymphedema (swelling of hands and feet at birth)
    • Hearing loss

 

Diagnosis

Turner Syndrome is diagnosed through:

  1. Clinical Examination:
    • Physical signs such as short stature and webbed neck folds provide initial clues.
  2. Karyotyping (Chromosome Analysis):
    • A blood test identifies missing or structurally abnormal X chromosomes.
  3. Prenatal Diagnosis:
    • Turner Syndrome can be detected during pregnancy through:
      • Amniocentesis or chorionic villus sampling (CVS)
      • Ultrasound findings, such as nuchal translucency (fluid collection at the neck).

Treatment

Although Turner Syndrome cannot be cured, treatments focus on managing symptoms and improving quality of life:

  1. Growth Hormone Therapy:
    • Administered during childhood to increase height.
  2. Estrogen Replacement Therapy (HRT):
    • Promotes the development of secondary sexual characteristics (e.g., breast development) and helps maintain bone density.
  3. Regular Medical Monitoring:
    • Regular checks for heart, kidney, and thyroid problems.
  4. Psychological Support:
    • Counseling to address emotional and social challenges, including infertility.

2. Other Organic Causes

  • Thyroid Dysfunction:
    • Hypothyroidism (underactive thyroid): Delays puberty as thyroid hormones play a critical role in metabolism and development.
  • Chronic Diseases:
    • Conditions such as inflammatory bowel disease, cystic fibrosis, kidney failure, or celiac disease can delay puberty if inadequately managed.
  • Gonadal Dysgenesis:
    • Maldevelopment of the ovaries can also cause delayed pubert